Illumina Inc. (ILMN) scored on five pillars from its reported financial statements, and ranked against 212 Healthcare companies.
Illumina Inc. (ILMN) scores 6.6 out of 10 as of , computed from its reported financial statements. That reads as solid quality. The reading rests on solvency, and predictability is what holds it back.
Data provided by Twelve Data. Scores are computed by Lemma Analysis from reported financials.
We cannot judge Illumina Inc. yet, because fewer than five years had both a return on capital and a cost of capital we could measure. This is not a “no”.
Quantitative signs of a moat, read from the filed statements. This is not a judgement of where it comes from (brand, network effects, switching costs). How Lemma measures a moat →
Illumina Inc. (ILMN) has a Lemma Quality Score of 6.6 out of 10 as of October 19, 2026, which reads as solid quality. A solid reading is a respectable business with clear strengths and at least one area that falls short of the best in its field. Five pillars feed it, and every one of them is computed from what the company reported rather than from its share price.
Ranked with the 212 Healthcare companies Lemma publishes, the score sits at the 84th percentile, inside the top quarter of the group. The median across the group is 4.4, and the top quarter begins at 6.0, so Illumina Inc. is well above the typical company here.
Illumina Inc.’s profitability score is 8.6 out of 10 (strong). Against a median of 2.7 among 210 Healthcare companies, that is well above the group and the 93rd percentile. Returns and margins at this level leave room to reinvest, absorb a bad year or return cash to shareholders without straining the business.
Solvency scores 9.0 out of 10, which reads as strong. The median across 150 Healthcare companies is 6.5, so Illumina Inc. is well above its peers on this pillar and ranks at the 79th percentile. A high solvency score means leverage is modest relative to earnings and cash flow, which gives management room to act in a bad year.
On growth, Illumina Inc. scores 4.9, an average reading. Its peers have a median of 4.9 across 107 Healthcare companies, which places it in line with them, at the 50th percentile. Average growth reflects a business expanding at roughly the pace of its sector, without a clear acceleration or decline.
On efficiency, Illumina Inc. scores 6.4, an average reading. Its peers have a median of 6.0 across 200 Healthcare companies, which places it in line with them, at the 55th percentile. Efficiency near the median says the operation is neither unusually lean nor unusually capital hungry.
Illumina Inc.’s predictability score is 3.7 out of 10 (weak). Against a median of 3.4 among 207 Healthcare companies, that is in line with the group and the 53rd percentile. When results are this uneven, the averages behind the other pillars hide a lot of movement, and a longer history tells more than the latest year.
This is a lopsided profile. Solvency scores 9.0 but predictability only 3.7, a gap of 5.3 points, so the overall hides a business that is excellent in one respect and weak in another. A solvency lead means the balance sheet is the company’s strongest asset, a cushion that buys time when trading gets harder. A predictability shortfall means the record is volatile, so the averages behind the other pillars move more than they appear to.
Every scored pillar is at or above the median of Healthcare companies, so there is no catch-up left to lift the overall. The risk runs the other way: a one point fall in profitability, the heaviest of them, would take the score from 6.6 to about 6.3. All five pillars could be scored, so the overall uses the full set of weights out of 100: profitability 25, solvency 20, growth 20, efficiency 15, predictability 20.
These are the Healthcare companies closest to Illumina Inc. in market value. Each has its own page scored on the same five pillars, so the comparison is like for like.
How much profit the company generates from its capital and sales.
The company’s ability to service debt and meet its obligations.
How fast revenue, earnings and cash flow are compounding.
How well assets and earnings convert into cash and output.
How stable and consistent results have been over time.
Each metric is scored from 0 to 10 against sector-aware benchmarks, where higher is better. Metrics roll up into five pillars, and the pillars combine into the overall score using the weights shown. Sector-sensitive metrics are judged relative to peers in the same sector.
This score is a systematic, backward-looking read of reported fundamentals. It does not judge valuation, management quality, competitive moat, or future prospects, and can be distorted by one-off items or unusual accounting. Treat it as a starting point, not a recommendation.
Educational only. Not investment advice.
On this reading Illumina Inc. scores 6.6 out of 10, which reads as solid quality. Its strongest pillar is solvency, its weakest is predictability. Quality is not the same as a good investment: the score says nothing about the price you would pay.
Illumina Inc. ranks at the 84th percentile of the 212 Healthcare companies Lemma publishes a score for. The median there is 4.4 and the top quarter starts at 6.0, against Illumina Inc.’s 6.6.
Five pillars, each scored from 0 to 10 against sector-aware benchmarks and then weighted into one overall reading: profitability, solvency, growth, efficiency and predictability. Everything comes from reported financials, and nothing comes from price, sentiment or forecasts.
This page last changed on October 19, 2026. The score moves with the financial statements, so the page changes when a new filing moves the reading rather than on a schedule. Live figures for ILMN are in the app.
No. Quality and valuation are separate questions, and a good business at the wrong price is still a bad purchase. Score the business here, then price it with a DCF you control.
Inside Lemma Analysis the same five pillars run on every company we cover, with the metrics behind each one, current fundamentals, a DCF you control and a watchlist that tells you when the price catches up.
Free to start · No credit card